Arca Biopharma | ABIO - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 8.66B 961M 2025-12
Arca Biopharma USD 469M 17.79M 2025-12
Biogen USD 18.21B 573.5M 2025-09
Brainstorm Cell Therapeutics USD -9.98M 2.29M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Capricor Therapeutics USD 305.79M 221.92M 2025-12
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -659.62M 138.5M 2025-12
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
Otsuka Holdings JPY 3.03T 174.32B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
United Therapeutics USD 7.1B 506M 2025-12